SCHEMBL4748253

SCHEMBL4748253

O=c1nc2n(-c3ccc(N4CCCCC4)cc3)c3cc(Cl)ccc3nc-2c(=O)n1CCCN1CCCC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GSR P00390 6/20 0.48
TMEM97 Q5BJF2 5/20 0.45
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
HTR1A P08908 4/20 0.41
HTR7 P34969 4/20 0.41
ALOX5 P09917 1/20 0.39
MC4R P32245 1/20 0.38
NPY1R P25929 1/20 0.38
HTR2A P28223 2/20 0.38
SLC6A4 P31645 2/20 0.38
HRH1 P35367 2/20 0.38
DRD3 P35462 2/20 0.38
DRD2 P14416 1/20 0.37
HTR2C P28335 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4747565 0.94 GSR (0.48) GSRTMEM97KDM4EALDH1A1HPGD
SCHEMBL4744199 0.89 KCNH2 (0.48) GSRTMEM97KDM4EALDH1A1HPGD
SCHEMBL4748220 0.89 GSR (0.48) GSRTMEM97KDM4EALDH1A1HPGD
SCHEMBL14069128 0.86 MC4R (0.41) GSRKDM4EALDH1A1HTR7MC4R
SCHEMBL4744550 0.86 TMEM97 (0.47) GSRTMEM97KDM4EALDH1A1HPGD
SCHEMBL4746291 0.85 TMEM97 (0.49) GSRTMEM97MC4RNPY1R
SCHEMBL4744200 0.83 GSR (0.46) GSRKDM4EALDH1A1HPGDHTR1A
SCHEMBL4744848 0.81 GSR (0.40) GSRHTR7MC4R
SCHEMBL4748222 0.75 HRH3 (0.47) GSRALDH1A1MC4R
SCHEMBL4744753 0.75 ACP1 (0.40) GSRMC4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008114009-A1 10H-BENZO(G)PTERDINE-2,4-DIONE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS CAMBRIDGE ENTERPRISE LTD. (GB) 2008-09-25 WO disclosed
WO-2008114009-A1 10H-BENZO(G)PTERDINE-2,4-DIONE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS CAMBRIDGE ENTERPRISE LTD. (GB) 2008-09-25 WO disclosed